1. Population pharmacokinetic analysis of rebamipide in healthy Korean subjects with the characterization of atypical complex absorption kinetics

   • Lien Ngo
   • Hee-Doo Yoo
   • Yong-Bok Lee

   Original Paper 18 March 2017 Pages: 291 - 303

   

2. Age-structured population model of cell survival

   • Wojciech Krzyzanski
   • Pawel Wiczling
   • Asfiha Gebre

   Original Paper 29 March 2017 Pages: 305 - 316

   

3. The effect of using a robust optimality criterion in model based adaptive optimization

   • Eric A. Strömberg
   • Andrew C. Hooker

   Original Paper Open access 06 April 2017 Pages: 317 - 324

   

4. Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches

   • Rasmus Vestergaard Juul
   • Joakim Nyberg
   • Trine Meldgaard Lund

   Original Paper 07 April 2017 Pages: 325 - 333

   

5. Estimation of QT interval prolongation through model-averaging

   • Peter L. Bonate

   Original Paper 18 April 2017 Pages: 335 - 349

   

6. Impact of altered endogenous IgG on unspecific mAb clearance

   • Saskia Fuhrmann
   • Charlotte Kloft
   • Wilhelm Huisinga

   Original Paper 24 April 2017 Pages: 351 - 374

   

7. Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics

   • Alanna S. Ocampo-Pelland
   • Marc R. Gastonguay
   • Matthew M. Riggs

   Original Paper 02 May 2017 Pages: 375 - 388

   

8. A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds

   • Michiel J. van Esdonk
   • Jacobus Burggraaf
   • Jasper Stevens

   Original Paper Open access 11 May 2017 Pages: 389 - 400